Physician profile
Patrick Wolcott
NPI 1891722120
$1,239.23
in general payments reported to CMS, 2019-2025
10 companies · $64.83 in 2025
The $64.83 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $63.99 · 2021: $126 · 2022: $125 · 2023: $408 · 2024: $321 · 2025: $64.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.66 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $328.75 | 2019-2024 | Watchman Flx |
| 3b Medical, INC. | $233.01 | 2023-2025 | Luna |
| Philips North America LLC | $207.81 | 2019-2024 | (Di7) Home Pi Undivided |
| Harmony Biosciences LLC | $165.18 | 2023-2024 | Wakix |
| Noctrix Health, INC. | $136.92 | 2024 | Nidra |
| Glaxosmithkline, LLC. | $53.90 | 2020-2025 | Trelegy Ellipta |
| Jazz Pharmaceuticals INC. | $37.11 | 2019-2024 | |
| Inspire Medical Systems, INC. | $32.75 | 2023 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.58 | 2025 | Jascayd |
| Fisher & Paykel Healthcare INC | $21.22 | 2024 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Wolcott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.